Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.1 (
chymotrypsin
)
10,938
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two analogues of
alpha-MSH
(Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2), Ac-[Nle4, Asp5, D-Phe7, Lys10]alpha-MSH4-10NH2 and Ac-[Nle4, Asp5, D-Phe7, Lys10] alpha-MSH4-10-NH2, were synthesized, and the melanotropic activities of the peptides were compared in several bioassays. Potencies were determined in the in vitro frog and lizard skin bioassays and in the S91 melanoma cell tyrosinase assay. Both analogues were equipotent or more potent than
alpha-MSH
in all bioassays, and the activities of the analogues were prolonged compared to
alpha-MSH
. The two analogues were very resistant to inactivation by purified proteolytic enzymes (
alpha-chymotrypsin
, trypsin, and pepsin). The two peptides could be topically applied and transdermally delivered across the skin of mice in vivo, resulting in a shift from pheomelanogenesis to eumelanogenesis within follicular melanocytes. The cyclic analogue exhibited greater potency, prolonged activity, and stability against enzyme inactivation than did the linear peptide. The significance of the findings for the further design of melanotropin analogues is discussed, as in the possible relevance of these melanotropin analogues for use in biomedical studies.
...
PMID:Linear and cyclic alpha-melanotropin [4-10]-fragment analogues that exhibit superpotency and residual activity. 255 3
The fluorescein-labeled melanotropin [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe 7]-
alpha-MSH
, was prepared by solid-phase techniques of peptide synthesis. The biological actions of this analogue were determined in several melanocyte bioassays and were compared with the parent peptide [Nle4,D-Phe7]-
alpha-MSH
and the native hormone
alpha-MSH
. The fluorescein compound was a superpotent agonist with approximately 10 times more activity than
alpha-MSH
in both the frog and the lizard skin bioassays. Murine S91 melanoma cells assayed in vitro (tyrosinase bioassay) were as responsive to the fluorescein analogue as to
alpha-MSH
. The analogue exhibited ultraprolonged biological activity and the biological activities were unaffected by treatment of the analogue with
alpha-chymotrypsin
. The fluorescein-labeled melanotropin should prove useful for melanotropin receptor characterization.
...
PMID:Synthesis and biological evaluation of the superagonist [N alpha-chlorotriazinylaminofluorescein-Ser1,Nle4,D-Phe7]-al pha-MSH. 298 82
The relative stability of natural melanotropins and related synthetic analogues to serum and purified proteolytic enzymes was studied. Both alpha- and beta-MSH were rapidly inactivated by frog serum, but much more slowly by rat serum. beta-MSH was more stable than
alpha-MSH
to serum inactivation. Both alpha- and beta-MSH were rapidly inactivated by
alpha-chymotrypsin
and trypsin. The synthetic analogues, [Nle4, D-Phe7]-
alpha-MSH
and [Cys4, Cys10]-
alpha-MSH
, were totally resistant to inactivation by frog and rat serum enzymes. [Nle4, D-Phe7]-
alpha-MSH
was resistant to inactivation by
alpha-chymotrypsin
and trypsin, whereas [Cys4, Cys10]-
alpha-MSH
was partially resistant to these enzymes under similar conditions. Melanotropin analogues resistant to inactivation by serum enzymes may prove useful in a variety of physiological studies wherein natural melanotropins would be rapidly inactivated.
...
PMID:Enzymological studies of melanotropins. 633 6
Biocytin derivatives of a superpotent analogue of alpha-melanotropin, [Nle4,D-Phe7]-
alpha-MSH
, were prepared. [N alpha-Bct-Ser1, Nle4,D-Phe7]-
alpha-MSH
and [12-Bct-N alpha-dodecanoyl-Ser1,Nle4,D-Phe 7]-
alpha-MSH
were synthesized by solid-phase techniques, and the coupling of biotin and 12-aminododecanoic acid was achieved through their succinimido esters. These melanotropins possessed almost identical actions to [Nle4,D-Phe 7]-
alpha-MSH
as determined by several melanocyte bioassays. Both biocytin derivatives were highly potent agonists and exhibited prolonged biological activity as determined in the frog and lizard skin bioassays. Both biotinylated peptides were at least equipotent to
alpha-MSH
in stimulating Cloudman S91 mouse melanoma tyrosinase activity. The analogues were resistant to inactivation by
alpha-chymotrypsin
.
...
PMID:Synthesis and biological actions of highly potent and prolonged acting biotin-labeled melanotropins. 643 88